VitalConnect raised $100 million to accelerate commercialization of its ambulatory cardiac monitoring device ... sells a disposable patch that records a patient’s heart rhythm to detect arrhythmias.

recording an average of over 7 days of heart monitoring. Despite US FDA approval, the Zio Patch has met slow acceptance possibly due to reimbursement hurdles. Explanations for the slow acceptance ...